BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26930535)

  • 1. A pilot randomized clinical trial evaluating the impact of genetic counseling for serious mental illnesses.
    Hippman C; Ringrose A; Inglis A; Cheek J; Albert AY; Remick R; Honer WG; Austin JC
    J Clin Psychiatry; 2016 Feb; 77(2):e190-8. PubMed ID: 26930535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the impact of a psycho-educational intervention for people diagnosed with schizophrenia and their primary caregivers in Jordan: a randomized controlled trial.
    Hasan AA; Callaghan P; Lymn JS
    BMC Psychiatry; 2015 Apr; 15():72. PubMed ID: 25885432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychiatric genetic counseling for serious mental illness: Impact on psychopathology and psychotropic medication adherence.
    Morris E; Batallones R; Ryan J; Slomp C; Carrion P; Albert A; Austin J
    Psychiatry Res; 2021 Feb; 296():113663. PubMed ID: 33360966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating genetic counseling for individuals with schizophrenia in the molecular age.
    Costain G; Esplen MJ; Toner B; Scherer SW; Meschino WS; Hodgkinson KA; Bassett AS
    Schizophr Bull; 2014 Jan; 40(1):78-87. PubMed ID: 23236078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual recovery among people with serious mental illnesses and substance problems: a qualitative analysis.
    Green CA; Yarborough MT; Polen MR; Janoff SL; Yarborough BJ
    J Dual Diagn; 2015; 11(1):33-41. PubMed ID: 25491440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating genetic counseling for family members of individuals with schizophrenia in the molecular age.
    Costain G; Esplen MJ; Toner B; Hodgkinson KA; Bassett AS
    Schizophr Bull; 2014 Jan; 40(1):88-99. PubMed ID: 23104866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community-implemented trauma therapy for former child soldiers in Northern Uganda: a randomized controlled trial.
    Ertl V; Pfeiffer A; Schauer E; Elbert T; Neuner F
    JAMA; 2011 Aug; 306(5):503-12. PubMed ID: 21813428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot randomised trial comparing a mindfulness-based stress reduction course, a locally-developed stress reduction intervention and a waiting list control group in a real-life municipal health care setting.
    Juul L; Pallesen KJ; Bjerggaard M; Nielsen C; Fjorback LO
    BMC Public Health; 2020 Mar; 20(1):409. PubMed ID: 32228533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoting stigma coping and empowerment in patients with schizophrenia and depression: results of a cluster-RCT.
    Gaebel W; Zäske H; Hesse K; Klingberg S; Ohmann C; Grebe J; Kolbe H; Icks A; Schneider F; Backes V; Wolff-Menzler C; Guse B; Gallinat J; Bock T; Jockers-Scherübl MC; Krüger T; Jessen F; Bechdolf A; Kircher T; Konrad C; Falkai P; Schaub A; Rudolph M; Köllner V; Schmid-Ott G; Linden M; Lieberei B; Stuhlinger M; Sommerfeld S; Schumacher A; Krenge S; Gereke S; Mönter N; Navarro-Urena A; Frosch G; Kuhlbusch FJ; Cleveland H; Riesbeck M
    Eur Arch Psychiatry Clin Neurosci; 2020 Aug; 270(5):501-511. PubMed ID: 31520149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Clinical Decision Support on Cardiovascular Risk Among Adults With Bipolar Disorder, Schizoaffective Disorder, or Schizophrenia: A Cluster Randomized Clinical Trial.
    Rossom RC; Crain AL; O'Connor PJ; Waring SC; Hooker SA; Ohnsorg K; Taran A; Kopski KM; Sperl-Hillen JM
    JAMA Netw Open; 2022 Mar; 5(3):e220202. PubMed ID: 35254433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes about smoking cessation treatment, intention to quit, and cessation treatment utilization among young adult smokers with severe mental illnesses.
    Brunette MF; Ferron JC; Aschbrenner KA; Pratt SI; Geiger P; Kosydar S
    Addict Behav; 2019 Feb; 89():248-255. PubMed ID: 30343187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing Stigma Toward Individuals With Schizophrenia Using a Brief Video: A Randomized Controlled Trial of Young Adults.
    Amsalem D; Yang LH; Jankowski S; Lieff SA; Markowitz JC; Dixon LB
    Schizophr Bull; 2021 Jan; 47(1):7-14. PubMed ID: 33484269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smoking Cessation Intervention for Severe Mental Ill Health Trial (SCIMITAR+): study protocol for a randomised controlled trial.
    Peckham E; Arundel C; Bailey D; Brownings S; Fairhurst C; Heron P; Li J; Parrott S; Gilbody S
    Trials; 2017 Jan; 18(1):44. PubMed ID: 28126031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Computer-Based Substance Use Screening and Brief Behavioral Counseling vs Usual Care for Youths in Pediatric Primary Care: A Pilot Randomized Clinical Trial.
    Knight JR; Sherritt L; Gibson EB; Levinson JA; Grubb LK; Samuels RC; Silva T; Vernacchio L; Wornham W; Harris SK
    JAMA Netw Open; 2019 Jun; 2(6):e196258. PubMed ID: 31225897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking cessation for people with severe mental illness (SCIMITAR+): a pragmatic randomised controlled trial.
    Gilbody S; Peckham E; Bailey D; Arundel C; Heron P; Crosland S; Fairhurst C; Hewitt C; Li J; Parrott S; Bradshaw T; Horspool M; Hughes E; Hughes T; Ker S; Leahy M; McCloud T; Osborn D; Reilly J; Steare T; Ballantyne E; Bidwell P; Bonner S; Brennan D; Callen T; Carey A; Colbeck C; Coton D; Donaldson E; Evans K; Herlihy H; Khan W; Nyathi L; Nyamadzawo E; Oldknow H; Phiri P; Rathod S; Rea J; Romain-Hooper CB; Smith K; Stribling A; Vickers C
    Lancet Psychiatry; 2019 May; 6(5):379-390. PubMed ID: 30975539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a Comprehensive Cardiovascular Risk Reduction Intervention in Persons With Serious Mental Illness: A Randomized Clinical Trial.
    Daumit GL; Dalcin AT; Dickerson FB; Miller ER; Evins AE; Cather C; Jerome GJ; Young DR; Charleston JB; Gennusa JV; Goldsholl S; Cook C; Heller A; McGinty EE; Crum RM; Appel LJ; Wang NY
    JAMA Netw Open; 2020 Jun; 3(6):e207247. PubMed ID: 32530472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychoeducation may reduce self-stigma of people with schizophrenia and schizoaffective disorder.
    Uchino T; Maeda M; Uchimura N
    Kurume Med J; 2012; 59(1-2):25-31. PubMed ID: 23257635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Individual Placement and Support Supplemented With Cognitive Remediation and Work-Focused Social Skills Training for People With Severe Mental Illness: A Randomized Clinical Trial.
    Christensen TN; Wallstrøm IG; Stenager E; Bojesen AB; Gluud C; Nordentoft M; Eplov LF
    JAMA Psychiatry; 2019 Dec; 76(12):1232-1240. PubMed ID: 31483451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Effects of an Intervention to Reduce Cardiovascular Risk for Patients With Bipolar Disorder, Schizoaffective Disorder, or Schizophrenia: A Randomized Clinical Trial.
    Rossom RC; Crain AL; Waring S; Sperl-Hillen JM; Hooker SA; Miley K; O'Connor PJ
    J Clin Psychiatry; 2023 Jul; 84(4):. PubMed ID: 37428030
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.